LEO INTERNATIONAL PRECISION HEALTH AG logo

LEO INTERNATIONAL PRECISION HEALTH AG (LEOW)

Market Closed
19 Aug, 06:02
XFRA XFRA
19. 40
0
0%
- Market Cap
- P/E Ratio
0.6% Div Yield
2,500 Volume
- Eps
19.4
Previous Close
Add Transaction
Day Range
19.4 19.4
Year Range
6 36
Want to track LEOW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LEOW closed Wednesday higher at €19.4, an increase of 0% from Tuesday's close, completing a monthly increase of 0% or €0. Over the past 12 months, LEOW stock gained 29.3333%.
LEOW pays dividends to its shareholders, with the most recent payment made on Jul 29, 2013.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

LEOW Chart

LEO INTERNATIONAL PRECISION HEALTH AG (LEOW) FAQ

What is the stock price today?

The current price is €19.40.

On which exchange is it traded?

LEO INTERNATIONAL PRECISION HEALTH AG is listed on XFRA.

What is its stock symbol?

The ticker symbol is LEOW.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, no market cap data is available.

Has LEO INTERNATIONAL PRECISION HEALTH AG ever had a stock split?

No, there has never been a stock split.

LEO INTERNATIONAL PRECISION HEALTH AG Profile

- Industry
- Sector
- CEO
XFRA Exchange
- ISIN
Germany Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

LEO INTERNATIONAL PRECISION HEALTH AG, often referred to as Leo International Precision Health AG, is a small healthcare-technology firm located in the Munich area of Germany. The company is publicly traded on the Frankfurt Stock Exchange under the symbol LEOW, among other related ticker codes. Leo International focuses primarily on the healthcare technology sector, specifically targeting precision health and medical technology solutions and services as opposed to traditional pharmaceutical manufacturing, which distinguishes it within the broader healthcare landscape.

The company’s registered office can be found in Garching bei München, placing it within a prominent ecosystem for life sciences and technological innovation in Germany. The organizational structure of the company adheres to the German stock-corporation (AG) law, featuring a supervisory board typical for publicly listed entities in Germany.

Leo International Precision Health AG has its roots connected to SPOBAG AG, a previously established Munich-based company that had limited operational activities before repositioning itself towards precision health. This evolution reflects an adaptive strategy in the rapidly changing healthcare technology arena. As a small-cap and specialized issuer, the firm may face limitations in terms of liquidity, research coverage, and financial disclosure compared to larger healthcare companies listed in Frankfurt. Investors are encouraged to examine official investor relations materials, company filings, and current trading data before making any decisions.

Products and Services

  • Precision Health Solutions

    The company offers tailored solutions designed to enhance health outcomes by utilizing advanced data analytics, allowing for personalized treatment and proactive medical interventions. These solutions leverage technology to facilitate patient-specific data management, ensuring that treatments and health advice are optimized for individual needs.

  • Medical Technology Services

    Leo International provides a range of medical technology services aimed at improving clinical operations and patient care. These services include the development and deployment of medical devices and support systems that enhance diagnosis, treatment efficacy, and patient monitoring. The focus is on integrating innovative technology into everyday healthcare practices.

  • Data Analytics and Management

    Offering advanced data analytics and management services, Leo International aids healthcare providers in making informed decisions based on comprehensive data sets. Their analytics platforms are designed to synthesize vast amounts of health-related data, enabling better resource allocation and improving overall healthcare delivery.

  • Research and Development Initiatives

    The company engages in research and development endeavors to foster innovation in precision health and medical technologies. This includes partnerships with academic institutions and other research organizations to advance the science of personalized medicine and health tech solutions.

  • Consulting Services

    Leo International offers consulting services to assist healthcare institutions in transitioning to precision health models. These services encompass strategic planning, implementation of cutting-edge technologies, and training for staff to adapt to new systems and protocols that improve patient care.

Contact Information

Address: Dieselstrasse 21
Phone: 49 89 552758 0